Moderna’s consensus price target has significantly declined from $119.26 to $47.5, indicating a cautious outlook from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback